Clarification sought from Dishman Pharmaceuticals and Chemicals

28 Mar 2017 Evaluate

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals on March 28, 2017, with reference to the news flashed on CNBC TV18 dated March 28, 2017 quoting ‘US FDA Approves Zejula Capsules’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×